Abstract:Objectives: To establish human periodontal ligament stem cells (hPDLSC) with high and stable expression of enhanced green fluorescent protein (eGFP) and to obtain an ideal vector expression system that suitable for gene therapy in periodontal tissue engineering.Methods: hPDLSCs were transfected with eGFP for 48 h via different MOI (25, 50, 100, 200 and 400) by lentiviral vector, the transfection efficiency was evaluated by fluorescent microscopy and flow cytometry, and transfected hPDLSCs proliferation was evaluated by MTT. Pluripotent, differentiation capacity and ALP expression status were determined further. Osteoblast-associated genes expressions for osteogenesis were evaluated by quantitative-PCR. In addition, rat molar periodontal fenestration defect model was used for evaluating periodontal tissue engineering.Results: The transfection efficiency after 48 h were 44.7%, 60.9%, 71.7%, 85.8%, and 86.9% respectively. There was no significant effect of transfection (at different MOI levels of 25, 50, 100, and 200) on the proliferation of hPDLSCs (designated as eGFP-hPDLSCs) compared with hPDLSCs (P > 0.05). However, proliferation of eGFP hPDLSCs at MOI 400 became slower (P < 0.05). Both eGFP hPDLSCs and hPDLSCs were able to differentiate into osteocytes and adipocytes under certain conditioned media. At 7 days, expression levels of COL-1, RUNX2 in hPDLSCS were higher than those in eGFP hPDLSCs (P < 0.05); expression levels of ALP and OPN in eGFP hPDLSCs were similar to those in hPDLSCs (P > 0.05). Newly regenerated bone formation was observed in the defect model used.Conclusions: Among the transfection conditions, 48 h transfection at MOI 200 is optimal for labelling hPDLSCs with eGFP in a lentiviral vector. There is no change in capability of the eGFP hPDLSCs osteogenesis. The lentiviral vector with eGFP is an appropriate expression vector system and hPDLSCs are ideal seeding cells for gene therapy in periodontal tissue engineering. (C) 2012 Elsevier Ltd. All rights reserved.

[Construction and Identification of Recombinant Human Platelet-Derived Growth Factor-B Adenoviral Vector and Transfection into Periodontal Ligament Stem Cells].

Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering.

Enhanced Growth of Recombinant Human Adenovirus Type 41 (Hadv-41) Carrying ADP Gene

Construction of recombinant adenoviruse vector containing bone human morphogenetic protein-7 and its expression in human periodontal ligament cells

Experimental Study on Human Periodontal Ligament Cells Transfected with Human Amelogenin Gene

Construction and identification of recombinant adenovirus expressing hPDGF-A and hBD2

Construction and identification of a replication deficient recombinant adenovirus encoding osteoprotegerin and fibroblast growth factor

Application of Egfp to Label Human Periodontal Ligament Stem Cells in Periodontal Tissue Engineering.

Reconstruction and Identification of Adenovirus Expression Vector for Human Transforming Growth Factor Β1

Platelet-derived Growth Factor BB Gene-Released Scaffolds: Biosynthesis and Characterization

PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration

Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering

Effects of Adenoviral-Mediated Coexpression of Bone Morphogenetic Protein-7 and Insulin-Like Growth Factor-1 on Human Periodontal Ligament Cells.

[Preparation of the High-Titer Retroviral Viruses for Transducting PDGF-A Gene].

Fabricating periodontal tissue engineering compound by gene modified gingival fibroblasts and acellular dermal matrix

Construction and identification of recombinant human bone morphogenetic protein-2 gene adenoviral vector

Novel Gene-Activated Matrix with Embedded Chitosan/plasmid DNA Nanoparticles Encoding PDGF for Periodontal Tissue Engineering.

[Construction of Recombinant Adenovirus Vector of Mouse Keratinocyte Growth Factor].

Validation Of Human Periodontal Ligament-Derived Cells As A Reliable Source For Cytotherapeutic Use

Establishment and identification of small hairpin interfering RNA eukaryotic expression vectors of human platelet-derived growth factor A

The Effects of Platelet-Derived Growth Factor-BB on Human Dental Pulp Stem Cells Mediated Dentin-Pulp Complex Regeneration